(Q40609920)

22 September 2017

Spectrum of virus inhibition by consensus interferon YM643. (English)

1 reference

22 September 2017

S Yasuda

1

1 reference

22 September 2017

J H Huffman

2

1 reference

22 September 2017

D F Smee

3

1 reference

22 September 2017

R W Sidwell

4

1 reference

22 September 2017

K Miyata

5

1 reference

22 September 2017

1 September 2000

1 reference

Antiviral Chemistry & Chemotherapy

22 September 2017

1 reference

22 September 2017

11

1 reference

22 September 2017

5

1 reference

22 September 2017

337-341

1 reference

Initial and innate responses to viral infections--pattern setting in immunity or disease

22 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100504

The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100504

Antiherpetic effects of a human alpha interferon analog, IFN-alpha Con1, in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100504

Re-treatment of chronic hepatitis C with consensus interferon .

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100504

Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon. The Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100504

Cultured human myocardial fibroblasts of pediatric origin: natural human interferon-alpha is more effective than recombinant interferon-alpha 2a in carrier-state coxsackievirus B3 replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100504

Avoiding viral contamination in biotechnological and pharmaceutical processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100504

Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100504

A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100504

Cell-based and animal models for hepatitis B and C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100504

Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100504

10.1177/095632020001100504

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference